Shilpa Biologicals Pvt. Ltd. launched Partner Power, a purpose-built digital transparency platform that provides global sponsors with uninterrupted, real-time insights into every stage of their biologics development and manufacturing programs.

Engineered as a unified digital ‘data fabric,’ PartnerPower replaces traditional periodic reporting with a continuously live, collaborative environment — enabling biopharmaceutical developers worldwide to monitor the true ‘state of affairs’ of their projects at any moment, from anywhere in the world. It delivers real-time visibility into process development laboratories and GMP manufacturing environments, providing sponsors with direct access to operational data as it is generated. By linking information across R&D, analytical development, and manufacturing operations, the platform is designed to support closer coordination, faster decision-making, and more efficient technology transfer.

The launch is another component of Shilpa Biologicals’ wider strategy to elevate the global CDMO experience from transactional outsourcing to a fully integrated, partnership-driven model. 

The platform has also been designed with data integrity and sponsor confidentiality as core principles and aligned with the expectations of global regulatory authorities – including the US FDA, EMA, and PMDA – it enables a continuous state of audit readiness.

Madhav Bhutada, Director, Shilpa Biologicals, commented: “With PartnerPowerTM, we are setting a new global benchmark for what transparency in a CDMO partnership should look like. It allows our sponsors to innovate with complete confidence, knowing that every data point, every decision, and milestone is visible to them in real time.”